Ultromics
ultromics.com
Actively hiring
Medical Imaging Systems
Medical AI
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$88M
14 rounds on record
Latest round
Venture round
Nov 2025 · 10 mo ago
Team
201-500
employees, estimated range
Grants
1
1 grant · CORDIS
Backers
5
Future Planet Capital, GV
The money's age
Fresh money
10 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 26, 2025
Raised a round Venture round
Jul 31, 2025
Raised a round Series C $55M
Nov 27, 2024
Raised a round Venture round
Nov 20, 2024
Certified Ultromics obtains Breakthrough Device FDA clearance for its Cardiac Amyloidosis screening device through the Total Product Lifecycle Advisory Program · PRNewswire
Sep 20, 2023
Raised a round Venture round
Feb 7, 2023
Raised a round Venture round
May 26, 2022
Raised a round Venture round
Nov 9, 2021
Partnership Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands · Nasdaq
Aug 16, 2021
Raised a round Series B $33M
Aug 10, 2021
Raised a round Venture round
Mar 30, 2021
Raised a round Venture round
Dec 1, 2020
Raised a round Venture round
Jan 1, 2019
Won a grant CORDIS
Aug 28, 2018
Raised a round Venture round
Feb 22, 2018
Raised a round Venture round
Nov 10, 2017
Raised a round Venture round
Mar 22, 2017
Founded per the company register
Tractionpublic signals, read monthly
Web presence
top 3%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Series C | Jul 2025 | $55M | — | mobihealthnews.com |
| Venture round | Nov 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Sep 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Feb 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | May 2022 | — | — | find-and-update.company-information.service.gov.uk |
| Series B | Aug 2021 | $33M | — | mddionline.com |
| Venture round | Aug 2021 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Mar 2021 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Dec 2020 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Jan 2019 | — | — | CORDIS |
| Venture round | Aug 2018 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Feb 2018 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Nov 2017 | — | — | find-and-update.company-information.service.gov.uk |
Registers and programsofficial lists and records that name the company
| Legal entity | ULTROMICS LIMITED | Companies House |
| Registered | 22 Mar 2017 |
Backed byfrom the funds' portfolios and accelerator catalogs
Future Planet Capital 
GV 
Nina Capital 
Optum Ventures 
Oxford Science Enterprises Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Cleerly is a healthcare company founded in 2017 that applies deep learning to cardiac computed tomography scans to characterise coronary…
Subtle Medical is a company founded in 2017 out of Stanford research that uses deep learning to improve medical imaging acquisition. Its…
Us2.ai automates the analysis and reporting of echocardiograms. Its software measures cardiac function without manual tracing. The company…
Shukun Technology builds medical imaging artificial intelligence for cardiovascular, neurological and oncology diagnosis in Chinese…
AZmed builds artificial intelligence that detects fractures and lesions on radiographs. Its Rayvolve software supports emergency radiology…
AIRS Medical is a Seoul company founded in 2018 that accelerates magnetic resonance imaging with deep learning. Its SwiftMR software…
Overview
Ultromics is an Oxford company founded in 2017 that applies machine learning to echocardiography. Its EchoGo software detects heart failure and coronary disease patterns that are easy for clinicians to miss on ultrasound images. The company holds American regulatory clearances and works with hospitals in Britain and the United States.
News
New AHA report highlights Ultromics' AI tool's benefit in earlier heart failure diagnosis
The AHA's Impact Report was created using independent clinical and image data through its AI Assessment Lab.
Read more
Report
Ultromics Secures Strategic Investment from the American Heart Association
Ultromics, a pioneer in AI-driven cardiology solutions, today announced an investment from the American Heart Association
Read more
Report
Ultromics Study Shows AI Could Improve Early Detection of Cardiac Amyloidosis
Ultromics, a pioneer in AI-driven cardiology solutions, today announced findings from its new study on artificial intelligence (AI) in echocardiography, presented at the American Society of Echocardiography
Read more
Report
Ultromics nets $55M to boost its AI ultrasound software for detecting hidden heart failure
Read more
Report
Ultromics: $55 Million Series C Raised For AI-Based Cardiology Solutions
Ultromics, a leader in AI-driven cardiology solutions, has raised $55 million in Series C financing. This funding round was co-led by L&G, Allegis Capital, and Lightrock, with additional support from organizations like Oxford Science Enterprises and UCHIC
Read more
Report
Ultromics Lands $55M Series C to Tackle Undiagnosed Heart Failure at Scale
AI heart failure diagnostics innovator makes it possible to catch deadly heart failure earlier by analyzing the most common heart scan in the world and...
Read more
Report
Ultromics obtains Breakthrough Device FDA clearance for its Cardiac Amyloidosis screening device through the Total Product Lifecycle Advisory Program
/PRNewswire/ -- Ultromics
Read more
Report
Ultromics Limited
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for Ultromics Limited reflects the research output of authors from Ultromics Limited who published articles in the 145 journals included i
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Oxford
United Kingdom
HQ
200-500 est. staff
Financials
Total raised
$88M
Latest round
Venture - Series Unknown
Funding rounds
14
Investors
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | — | Details |
| Series C | 2025 | $55M | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Venture - Series Unknown | 2023 | — | Details |
| Venture - Series Unknown | 2023 | — | Details |
| Venture - Series Unknown | 2022 | — | Details |
| Series B | 2021 | $33M | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Venture - Series Unknown | 2020 | — | Details |
| Grant | 2019 | — | Details |
| Venture - Series Unknown | 2018 | — | Details |
| Venture - Series Unknown | 2018 | — | Details |
| Venture - Series Unknown | 2017 | — | Details |
Key Investors